Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Amphastar Pharmaceuticals, Inc
F:29A
Amphastar Pharmaceuticals, Inc
F:29A
Price:
23.07
EUR
-1.95%
Market Closed
Market Cap:
€1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Amphastar Pharmaceuticals, Inc
F:29A
|
US |
|
PSP Swiss Property AG
SIX:PSPN
|
CH |
|
B
|
British Land Company PLC
F:BLD
|
UK |
|
Advanced Micro Devices Inc
NASDAQ:AMD
|
US |
|
P
|
Polynet PCL
SET:POLY
|
TH |
|
K
|
Karoon Energy Ltd
F:LBL
|
AU |
|
M
|
Metro Systems Corporation PCL
SET:MSC
|
TH |
|
T
|
Telefonaktiebolaget LM Ericsson
DUS:ERCB
|
SE |
|
J
|
JNTC Co Ltd
KOSDAQ:204270
|
KR |
Wall St Price Targets
29A Price Forecast
Based on 9 analysts
Based on 9 analysts
-25% Downside
from
€23.07
today
Amphastar Pharmaceuticals, Inc (29A)’s 12-month stock price forecast through October 2027 has a consensus target of €17.4, implying 25% downside. The forecast is based on price targets from 9 Wall Street analysts.
29A Analyst Rating
No ratings yet
No ratings yet
Amphastar Pharmaceuticals, Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 29A's stock price target?
Price Target
17.4
EUR
17.4
EUR
According to Wall Street analysts, the average 1-year price target for 29A is 17.4 EUR with a low forecast of 16.41 EUR and a high forecast of 25.59 EUR.
What is the Revenue forecast for Amphastar Pharmaceuticals, Inc?
Projected CAGR
3%
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 6 years is 3%.
What is the Gross Profit forecast for Amphastar Pharmaceuticals, Inc?
Projected CAGR
6%
6%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 11%. The projected CAGR for the next 3 years is 6%.
What is the Operating Income forecast for Amphastar Pharmaceuticals, Inc?
Projected CAGR
13%
13%
Over the last 13 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 13%.
What is the Pre-Tax Income forecast for Amphastar Pharmaceuticals, Inc?
Projected CAGR
16%
16%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 13%. The projected CAGR for the next 3 years is 16%.
What is the Net Income forecast for Amphastar Pharmaceuticals, Inc?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 6 years is 4%.